CH637827A5 - Procede de fabrication de preparations solides contenant du gefarnate. - Google Patents

Procede de fabrication de preparations solides contenant du gefarnate. Download PDF

Info

Publication number
CH637827A5
CH637827A5 CH243379A CH243379A CH637827A5 CH 637827 A5 CH637827 A5 CH 637827A5 CH 243379 A CH243379 A CH 243379A CH 243379 A CH243379 A CH 243379A CH 637827 A5 CH637827 A5 CH 637827A5
Authority
CH
Switzerland
Prior art keywords
gefarnate
solid
pka
preparations containing
solid preparations
Prior art date
Application number
CH243379A
Other languages
English (en)
French (fr)
Inventor
Muneo Hara
Terutsugu Tsuji
Keiichi Matsuda
Tadashi Umezu
Munetoshi Adachi
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of CH637827A5 publication Critical patent/CH637827A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH243379A 1978-03-14 1979-03-14 Procede de fabrication de preparations solides contenant du gefarnate. CH637827A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53029746A JPS6026093B2 (ja) 1978-03-14 1978-03-14 ゲフアルナート含有固型製剤の製造方法

Publications (1)

Publication Number Publication Date
CH637827A5 true CH637827A5 (fr) 1983-08-31

Family

ID=12284653

Family Applications (1)

Application Number Title Priority Date Filing Date
CH243379A CH637827A5 (fr) 1978-03-14 1979-03-14 Procede de fabrication de preparations solides contenant du gefarnate.

Country Status (17)

Country Link
JP (1) JPS6026093B2 (ja)
AR (1) AR218711A1 (ja)
BE (1) BE874795A (ja)
CH (1) CH637827A5 (ja)
CS (1) CS207784B2 (ja)
ES (1) ES8200632A1 (ja)
FR (1) FR2419729B1 (ja)
GB (1) GB2016271B (ja)
HK (1) HK49283A (ja)
IE (1) IE48269B1 (ja)
IT (1) IT1162282B (ja)
MT (1) MTP843B (ja)
MX (1) MX5996E (ja)
NL (1) NL7901917A (ja)
PH (1) PH16903A (ja)
PT (1) PT69341A (ja)
ZA (1) ZA791103B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0391851A1 (de) * 1989-04-07 1990-10-10 Ciba-Geigy Ag Pestizide Wirkstoffkonzentrate und ihre Herstellung

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
JPS5635169B2 (ja) * 1974-02-14 1981-08-15
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
JPS53148519A (en) * 1977-05-31 1978-12-25 Sumitomo Chem Co Ltd Preparation of solid medicine containing gefarnate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0391851A1 (de) * 1989-04-07 1990-10-10 Ciba-Geigy Ag Pestizide Wirkstoffkonzentrate und ihre Herstellung

Also Published As

Publication number Publication date
IT7948332A0 (it) 1979-03-13
PH16903A (en) 1984-04-10
MX5996E (es) 1984-09-18
IE790725L (en) 1979-09-14
AR218711A1 (es) 1980-06-30
BE874795A (fr) 1979-07-02
HK49283A (en) 1983-11-11
IE48269B1 (en) 1984-11-28
MTP843B (en) 1980-02-11
ZA791103B (en) 1980-03-26
CS207784B2 (en) 1981-08-31
FR2419729B1 (fr) 1988-07-08
IT1162282B (it) 1987-03-25
ES478539A0 (es) 1981-11-01
GB2016271B (en) 1982-09-02
FR2419729A1 (fr) 1979-10-12
GB2016271A (en) 1979-09-26
NL7901917A (nl) 1979-09-18
ES8200632A1 (es) 1981-11-01
PT69341A (fr) 1979-04-01
JPS54122718A (en) 1979-09-22
JPS6026093B2 (ja) 1985-06-21

Similar Documents

Publication Publication Date Title
EP0233853B1 (fr) Couples effervescents, compositions effervescentes d'antagonistes H2 de l'histamine les contenant et leur préparation
EP0287488B1 (fr) Médicament, produit diététique et produit d'hygiène sous la forme d'une composition pulvérulente obtenue par adsorption de principes actifs sur un sucre à dissolution rapide et procédé d'obtention de ladite composition
CH679011A5 (ja)
FR2578421A1 (fr) Compositions pharmaceutiques utiles pour le traitement des troubles de la memoire
JP4621326B2 (ja) テプレノンの安定化組成物
FR2550092A1 (fr) Preparation medicamenteuse solide a deux phases et son procede d'obtention
FR2459660A1 (fr) Particules spheriques de charbon active utiles comme antidote, procede pour leur preparation et composition pharmaceutique les contenant
FR2670488A1 (fr) Composition pharmaceutique contenant une forme physique particuliere d'un amide heterocyclique et son procede de preparation.
CA2083683C (en) Stable formulation of analapril salt, a process for the preparation thereof and the use thereof
JP3285410B2 (ja) アントシアノシド類を含有する経口医薬組成物
CH642358A5 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant.
BE1005115A5 (fr) Compositions pharmaceutiques contenant des derives de furanne.
CA1095520A (fr) Procede de preparation de nouveaux derives de 20,21- dinoreburnamenine
CH637827A5 (fr) Procede de fabrication de preparations solides contenant du gefarnate.
EP1137653B1 (fr) Troxerutine a forte teneur en trihydroxy-ethyl-rutoside et procede de preparation
CA1140155A (fr) PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU 1.alpha.,25-DIHYDROXY CHOLECALCIFEROL
CA1151067A (fr) COMPOSITIONS PHARMACEUTIQUES ANTIARYTHMIQUES A ACTION PROLONGEE DONT LE PRINCIPE ACTIF EST 1'.alpha.-/2-/BIS (1-METHYL ETHYL) AMINO (ETHYL) .alpha.-PHENYL 2-PYRIDINE ACETAMIDEOU L'UN DE SES SELS
JPH08277216A (ja) 粉末剤および薬物の放出速度制御方法
JP3547783B2 (ja) 胃炎、胃・十二指腸潰瘍の予防及び治療剤
CA1186311A (fr) Procede de preparation de nouveaux derives de 20,21- d'inoreburnamenine eventuellement substitues sur le cycle e
BE1004182A3 (fr) Compositions pharmaceutiques contenant un compose a activite agoniste selective aux recepteurs analogues a la 5-ht1.
JPS63119426A (ja) 肝疾患治療薬組成物
FR2616068A1 (fr) Procede de stabilisation des principes actifs de produits vegetaux et les compositions pharmaceutiques renfermant lesdits principes actifs stabilises
LU84530A1 (fr) Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide
US8821924B2 (en) Rhein or diacerein compositions

Legal Events

Date Code Title Description
PUE Assignment

Owner name: BOEHRINGER INGELHEIM ITALIA S.P.A.

PL Patent ceased